Comparison of surgical difficulty in patients with resectable non-small cell lung cancer under different neoadjuvant treatment modes: a retrospective cohort study

BACKGROUND: Previous studies have reported on the efficacy and safety of neoadjuvant use of a programmed cell death 1 (PD-1) antibody, sintilimab, in patients with non-small cell lung cancer (NSCLC). This study aimed to further evaluate the difficulty of this surgery and the postoperative complicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Qiu, Bin, Ji, Ying, Guo, Wei, Li, Ning, Xue, Qi, Gao, Shugeng, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575808/
https://www.ncbi.nlm.nih.gov/pubmed/34795911
http://dx.doi.org/10.21037/jtd-21-1007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575808/
https://www.ncbi.nlm.nih.gov/pubmed/34795911
http://dx.doi.org/10.21037/jtd-21-1007

Ejemplares similares